Today
-0.75%
5 Days
-1.35%
1 Month
+5.82%
6 Months
+22.52%
Year to Date
+6.14%
1 Year
+25.05%
• Veeva reported strong second-quarter results and raised its full-year financial guidance. • Accelerated customer adoption and Vault CRM momentum drove double-digit revenue expansion. • Multiple analysts raised price targets following the upbeat earnings report.
• BrightSpring reported strong second-quarter revenue and raised its full-year guidance. • Wall Street analysts maintained buy ratings with an average price target of $78.97. • Annual revenue reached $12.91 billion with a net profit of $190.67 million.
• HCA Healthcare reported strong quarterly operating results driven by robust patient admissions. • Institutional accumulation and strategic outpatient expansion reinforced positive investor sentiment and price momentum. • The company achieved annual revenue of $75.60B and net profit of $6.78B.
• Stryker shares faced volatility and profit-taking despite securing a U.S. defense contract modification. • Investors remain cautious regarding operational disruptions, cyber incident costs, and supply chain bottlenecks. • The company reported annual revenue of $25.12B and a net profit of $3.25B.
• Competitors received regulatory clearances, increasing market share concerns for Intuitive Surgical. • Management maintained conservative full-year guidance despite robust quarterly operational metrics. • Wall Street brokerages revised price targets downward due to hospital capital expenditure caution.
• Danaher reported second-quarter revenue and adjusted earnings exceeding Wall Street consensus estimates. • Julie Sawyer Montgomery was appointed as the new chief executive officer. • Danaher generated $24.57B in annual revenue with $3.61B in net profit.


| Shareholders | Proportion |
|---|---|
| Vanguard Capital Management, LLC | 6.53% |
| BlackRock Institutional Trust Company, N.A. | 4.71% |
| State Street Investment Management (US) | 4.47% |
| Capital World Investors | 2.96% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 53.12% |
| Investment Advisor/Hedge Fund | 29.79% |
| Research Firm | 2.97% |
| Pension Fund | 2.82% |
Related Instruments
Popular Instruments